Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Pancreatic Cancer
100%
Meta-analysis
100%
Patients with Diabetes Mellitus
100%
Cancer Inpatients
100%
Diabetes Risk
100%
Antidiabetic Drug
100%
Confidence Interval
66%
Sulfonylurea
44%
Adjusted Odds Ratio
44%
Insulin
33%
Metformin
33%
Thiazolidinediones
33%
Randomized Controlled Trial
22%
Odds Ratio
22%
Oncology
11%
Gastroenterology
11%
Pooled Analysis
11%
Cancer Outcomes
11%
Ratio Estimate
11%
Medication Use
11%
MEDLINE
11%
Embase
11%
Web of Science
11%
Random Effects Model
11%
Relative Risk Ratio
11%
Confounding by Indication
11%
Reverse Causality
11%
Medication-related Harm
11%
Medicine and Dentistry
Pancreas Cancer
100%
Diabetes Mellitus
100%
Meta-Analysis
100%
Systematic Review
100%
Patient with Diabetes
100%
Anti-Diabetic Medication
100%
Odds Ratio
66%
Sulfonylurea
44%
Glycon
33%
Thiazolidinedione
33%
Insulin
33%
Observational Study
22%
Randomized Controlled Trial
22%
Oncology
11%
Gastroenterology
11%
Prospective Study
11%
Pooled Analysis
11%
Random Effects Model
11%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Cancer
100%
Diabetes Mellitus
100%
Anti-Diabetic Medication
100%
Sulfonylurea
44%
Metformin
33%
Thiazolidinedione
33%
Insulin
33%
Observational Study
22%
Randomized Controlled Trial
22%
Gastroenterology
11%
Preclinical Study
11%
Prospective Study
11%
Random Effects Model
11%